Benitec Biopharma Inc. Annual Return On Equity in % from 2020 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Benitec Biopharma Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2024.
  • Benitec Biopharma Inc. Return On Equity for the quarter ending September 30, 2024 was -60.3 %, a 73.3% increase year-over-year.
  • Benitec Biopharma Inc. annual Return On Equity for 2024 was -90.1 %, a 67.1% increase from 2023.
  • Benitec Biopharma Inc. annual Return On Equity for 2023 was -274 %, a 38.3% decline from 2022.
  • Benitec Biopharma Inc. annual Return On Equity for 2022 was -198 %, a 90.4% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -90.1 +184 +67.1% Jul 1, 2023 Jun 30, 2024
2023 -274 -76 -38.3% Jul 1, 2022 Jun 30, 2023
2022 -198 -94.2 -90.4% Jul 1, 2021 Jun 30, 2022
2021 -104 -43.8 -72.5% Jul 1, 2020 Jun 30, 2021
2020 -60.4 Jul 1, 2019 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.